Amani Therapeutics, Inc.

New Filing
CIK: 0002099941·Other Health Care·DELAWARE·Filed: Dec 8, 2025
Total Offering

$31,120,000

Amount Sold

$31,120,000

Investors

2

First Sale

Nov 25, 2025

Offering Details

Type
Equity
Exemptions
Rule 506(b)

Related Persons

NameRole
Alice Lee
Executive Officer, Director
-- RTW Holdings VI, LLC
Promoter

Company

Amani Therapeutics, Inc.

40 10TH AVENUE

NEW YORK, NY, 10014

(646) 597-6980

SEC Filing

0002099941-25-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free